참고문헌
- Brinke A, Green PM, Giannelli F (1997). Characterization of the gene (VBP1) and transcript for the von Hippel-Lindau binding protein and isolation of the highly conserved murine homologue. Genomics, 45, 105-12. https://doi.org/10.1006/geno.1997.4902
- Coradini D, Speranza A (2005). Histone deacetylase inhibitors for treatment of hepatocellular carcinoma. Acta Pharmacol Sin, 26, 1025-33. https://doi.org/10.1111/j.1745-7254.2005.00195.x
- Delcuve GP, Khan DH, Davie JR (2013). Targeting class I histone deacetylases in cancer therapy. Expert Opin Ther Targets, 17, 29-41. https://doi.org/10.1517/14728222.2013.729042
- Farooq M, Sulochana KN, Pan X, et al (2008). Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. Dev Biol, 317, 336-53. https://doi.org/10.1016/j.ydbio.2008.02.034
- Fujioka Y, Taira T, Maeda Y, et al (2001). MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer. J Biol Chem, 276, 45137-44. https://doi.org/10.1074/jbc.M106127200
- Gahr S, Peter G, Wissniowski TT, et al (2008). The histone-deacetylase inhibitor MS-275 and the CDK-inhibitor CYC-202 promote anti-tumor effects in hepatoma cell lines. Oncol Rep, 20, 1249-56.
- Gingras AC, Gstaiger M, Raught B, Aebersold R (2007). Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol, 8, 645-54. https://doi.org/10.1038/nrm2208
- Glatter T, Wepf A, Aebersold R, Gstaiger M (2009). An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol Syst Biol, 5, 237.
- Guenther MG, Barak O, Lazar MA (2001). The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol, 21, 6091-101. https://doi.org/10.1128/MCB.21.18.6091-6101.2001
- Guenther MG, Yu J, Kao GD, Yen TJ, Lazar MA (2002). Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev, 16, 3130-5. https://doi.org/10.1101/gad.1037502
- Halkidou K, Gaughan L, Cook S, et al (2004). Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate, 59, 177-89. https://doi.org/10.1002/pros.20022
- Ito T, Chiba T, Ozawa R, et al (2001). A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA, 98, 4569-74. https://doi.org/10.1073/pnas.061034498
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Junttila MR, Saarinen S, Schmidt T, Kast J, Westermarck J (2005). Single-step Strep-tag purification for the isolation and identification of protein complexes from mammalian cells. Proteomics, 5, 1199-203. https://doi.org/10.1002/pmic.200400991
- Karagianni P, Wong J (2007). HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene, 26, 5439-49. https://doi.org/10.1038/sj.onc.1210612
- Kocher T, Superti-Furga G (2007). Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods, 4, 807-15. https://doi.org/10.1038/nmeth1093
- Lachenmayer A, Toffanin S, Cabellos L, et al (2012). Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J Hepatol, 56, 1343-50. https://doi.org/10.1016/j.jhep.2012.01.009
- Lamesch P, Li N, Milstein S, et al (2007). hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics, 89, 307-15. https://doi.org/10.1016/j.ygeno.2006.11.012
- Lin HY, Chen CS, Lin SP, Weng JR (2006). Targeting histone deacetylase in cancer therapy. Med Res Rev, 26, 397-413. https://doi.org/10.1002/med.20056
- Mori K, Maeda Y, Kitaura H, et al (1998). MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc. J Biol Chem, 273, 29794-800. https://doi.org/10.1074/jbc.273.45.29794
- Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M, Slavc I, Lubec G (2004). Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci, 2, 8. https://doi.org/10.1186/1477-5956-2-8
- Nakagawa M, Oda Y, Eguchi T, et al (2007). Expression profile of class I histone deacetylases in human cancer tissues. Oncol Rep, 18, 769-74.
- Noel ES, Casal-Sueiro A, Busch-Nentwich E, et al (2008).Organ-specific requirements for Hdac1 in liver and pancreas formation. Dev Biol, 322, 237-50. https://doi.org/10.1016/j.ydbio.2008.06.040
- Olsen JV, Schwartz JC, Griep-Raming J, et al (2009). A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed. Mol Cell Proteomics, 8, 2759-69. https://doi.org/10.1074/mcp.M900375-MCP200
- Pathil A, Armeanu S, Venturelli S, et al (2006). HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. Hepatology, 43, 425-34. https://doi.org/10.1002/hep.21054
- Qian-Lin Z, Ting-Feng W, Qi-Feng C, Min-Hua Z, Ai-Guo L (2010). Inhibition of cytosolic chaperonin CCTzeta-1 expression depletes proliferation of colorectal carcinoma in vitro. J Surg Oncol, 102, 419-23. https://doi.org/10.1002/jso.21625
- Quint K, Agaimy A, Di Fazio P, et al (2011). Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC. Virchows Arch, 459, 129-39. https://doi.org/10.1007/s00428-011-1103-0
- Satou A, Taira T, Iguchi-Ariga SM, Ariga H (2001). A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein. J Biol Chem, 276, 46562-7. https://doi.org/10.1074/jbc.M104937200
- Tsuchiya H, Iseda T, Hino O (1996). Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Cancer Res, 56, 2881-5.
- Uetz P, Giot L, Cagney G, et al (2000). A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature, 403, 623-7. https://doi.org/10.1038/35001009
- Vainberg IE, Lewis SA, Rommelaere H, et al (1998). Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell, 93, 863-73. https://doi.org/10.1016/S0092-8674(00)81446-4
- Venturelli S, Armeanu S, Pathil A, et al (2007). Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma. Cancer, 109, 2132-41. https://doi.org/10.1002/cncr.22652
- Walhout AJ, Sordella R, Lu X, et al (2000). Protein interaction mapping in C. elegans using proteins involved in vulval development. Science, 287, 116-22. https://doi.org/10.1126/science.287.5450.116
- Wen YD, Perissi V, Staszewski LM, et al (2000). The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci USA, 97, 7202-7. https://doi.org/10.1073/pnas.97.13.7202
- Wilson AJ, Byun DS, Popova N, et al (2006). Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem, 281, 13548-58. https://doi.org/10.1074/jbc.M510023200
- Witt O, Deubzer HE, Milde T, Oehme I (2009). HDAC family: What are the cancer relevant targets? Cancer Lett, 277, 8-21. https://doi.org/10.1016/j.canlet.2008.08.016
- Wong CW, Privalsky ML (1998). Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol, 18, 5500-10.
- Wu LM, Yang Z, Zhou L, et al (2010). Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma. PLoS One, 5, 14460. https://doi.org/10.1371/journal.pone.0014460
- Yang Z, Zhou L, Wu LM, et al (2010). Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy. Clin Chem Lab Med, 48, 1785-91.
- Yokota S, Yamamoto Y, Shimizu K, et al (2001). Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma. Cell Stress Chaperones, 6, 345-50. https://doi.org/10.1379/1466-1268(2001)006<0345:IEOCCC>2.0.CO;2
- Yue F, Wang LS, Xia L, et al (2009). Modulated T-complex protein 1 zeta and peptidyl-prolyl cis-trans isomerase B are two novel indicators for evaluating lymph node metastasis in colorectal cancer: Evidence from proteomics and bioinformatics. Proteomics Clin Appl, 3, 1225-35. https://doi.org/10.1002/prca.200900028
- Zhang Z, Yamashita H, Toyama T, et al (2005). Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*. Breast Cancer Res Treat, 94, 11-6. https://doi.org/10.1007/s10549-005-6001-1
피인용 문헌
- Epigenetic targets in hepatocellular carcinoma cells: identification of chaperone protein complexes with histone deacetylases vol.5, pp.5, 2013, https://doi.org/10.2217/epi.13.45
- In vitro Evaluation of Cytotoxic Activities of Essential Oil from Moringa oleifera Seeds on HeLa, HepG2, MCF-7, CACO-2 and L929 Cell Lines vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4671
- Targeting Histone Deacetylases in Diseases: Where Are We? vol.23, pp.1, 2015, https://doi.org/10.1089/ars.2013.5776
- Changes in the in vitro activity of platinum drugs when administered in two aliquots vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2731-1
- Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression vol.36, pp.7, 2017, https://doi.org/10.1038/onc.2016.257
- Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-32009-w